• OUR DATA
  • HOOVER'S ONDEMAND
  • OUR BLOG
 

ReGen Therapeutics Limited Sales Preparation

Who would have thought that cow's milk could help your brain? ReGen Therapeutics did. Its main product is Colostrinin, a polypeptide nutraceutical derived from ovine and bovine colostrums (the first milk produced after the birth of an offspring) that has been shown to have neurological benefits for sufferers of ailments such as Alzheimer's disease and multiple sclerosis. The supplement is marketed as CogniSure by licensee Metagenics in North America, Australia, and parts of Asia. It is sold by other partners in additional markets including the UK (MemoryAid), Poland, Turkey, Cyprus, and India. ReGen is working to expand sales of Colostrinin into new markets. 

Top Industries for ReGen Therapeutics Limited

Get relevant industry context to prepare for your next sales call – trends, competitors, news, call prep questions, and more.
View Industry Report

Key Financials

Understand a company’s financial condition to determine your best approach.
View Company Report

Financials  
Company Name PRIVATE
HEADQUARTERS
Market Value 0.7778
as of 2013-06-21
Fiscal Year-End Dec
2012 Sales (mil) -0.3149835
2012 Employees 0
Assets (mil) 0.1550688